Categories Uncategorized

Lung Cancer Not Just a Smoker’s Problem

February 4 is World Cancer Day, which makes this an ideal time to discuss smoking and lung cancer. Globally, lung cancer is one of the most common causes of cancer death, with estimates from the World Health Organization (“WHO”) showing that roughly 90% of lung cancer cases can be prevented by eliminating the use of tobacco.

Individuals who smoke have a high risk of developing this disease, with studies also linking smokeless tobacco to lung cancer. Did you know, however, that lung cancer can also develop in individuals who don’t use tobacco?

Dr. Aaron Mansfield, an oncologist who specializes in lung cancer, states that while the use of tobacco is the biggest risk factor for lung cancer development, there exists other risk factors that increase an individual’s risk of cancer of the lungs. Those factors include second-hand smoke, a family history of cancer of the lungs and being exposed to asbestos, radon gas and other carcinogens.

Symptoms of lung cancer, including chest pain and shortness of breath, may sometimes be mistaken for pneumonia. Mansfield explained that most of his patients had been diagnosed with pneumonia and prescribed antibiotics that didn’t benefit them before ending up at an oncologist. Other symptoms of lung cancer include headaches, bone pain, loss of weight, coughing up blood and a persistent cough.

A biopsy is usually needed to obtain a lung cancer diagnosis, with CT or ultrasound imaging being used to guide a needle’s placement in order to obtain an accurate tissue sample.

Dr. Karen Swanson, a critical care specialist and pulmonologist, stated that the key to a successful outcome was to detect lung cancer early because this allows the disease to be treated with ablation and radiation or removed through an operation.

Unfortunately, lung cancer symptoms rarely appear until the disease has spread to other organs in the body. Swanson explained that nearly 80% of the time, lung cancer had metastasized by the time an individual was diagnosed with the disease, noting that a tumor growing in a person’s lungs wasn’t something that the body could feel or sense, which made it hard for the tumor to be discovered while it was still in its early stages.

Swanson then suggested that individuals who have a history of smoking should discuss lung cancer screening with their primary care providers. It is recommended that individuals who have a high risk of developing lung cancer be screened annually with a low-dose CT scan.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is ‘One to Watch’

LIXTE is advancing a first-in-class PP2A inhibitor platform designed to enhance, rather than replace, established…

10 hours ago

The WHO Highlights Successes, Challenges to Global Health

The World Health Organization (WHO), the agency of the United Nations responsible for overseeing matters…

2 days ago

Experts’ Views on Screen Time and Lifestyle on Pediatric Brain Tumors

The young population faces an increasing health challenge posed by brain tumors affecting adolescents and…

1 week ago

New Approach Could Increase Response Rates for Cancer Immunotherapy

Immunotherapy, an approach that seeks to stimulate the immune system to attack and destroy cancer cells, is…

2 weeks ago

Oncotelic Therapeutics Inc. (OTLC) Unveils Breakthrough Nanomedicine Platform, Expands Everolimus (Afinitor(R)) Pipeline

OTLC’s Deciparticle(TM) platform reliably formulates diverse hydrophobic drugs—including macrolide mTOR inhibitors, peptides, and polyketides—into uniform,…

2 weeks ago

Soligenix Inc. (NASDAQ: SNGX) Extends SGX302 Clinical Success in Phase 2A Psoriasis Study

Soligenix reported that SGX302 was well tolerated by all patients in cohort 3, with no drug-related adverse events…

2 weeks ago